FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005642013> ?p ?o ?g. }

• W3005642013 endingPage "72" @default.
• W3005642013 startingPage "72" @default.
• W3005642013 abstract "Background and objectives: B-lymphoma Mo-MLV insertion region 1 (Bmi-1) is a stem cell factor that is overexpressed in various human cancer tissues. It has been implicated in cancer cell proliferation, cell invasion, distant metastasis, and chemosensitivity, and is associated with patient survival. Several reports have also identified Bmi-1 protein overexpression in endometrial carcinoma; however, the relationship between Bmi-1 expression and its significance as a clinicopathological parameter is still insufficiently understood. Accordingly, the present study aimed to clarify whether immunohistochemical staining for Bmi-1 in human endometrial carcinoma and normal endometrial tissues can be used as a prognostic and cell proliferation marker. Materials and Methods: Bmi-1 expression was assessed in endometrioid carcinoma (grade 1–3) and normal endometrial tissues (in the proliferative and secretory phases) by immunohistochemistry; protein expression was evaluated using the nuclear labeling index (%) in the hot spot. Furthermore, we examined other independent prognostic and proliferation markers, including the protein levels of Ki-67, p53, and cyclin A utilizing semi-serial sections of endometrial carcinoma tissues. Results: The expression of the Bmi-1 protein was significantly higher in all grades of endometrial carcinoma than in the secretory phase of normal tissues. Moreover, Bmi-1 levels tended to be higher in G2 and G3 tissues than in G1 tissue, without reaching significance. Bmi-1 expression showed no notable differences among International Federation of Gynecology and Obstetrics (FIGO) stages in endometrial carcinoma. Furthermore, we observed a significant positive relationship between Bmi-1 and Ki-67, cyclin A, or p53 by Spearman’s rank correlation test, implying that high Bmi-1 expression can be an independent prognostic marker in endometrial carcinoma. Conclusions: Our study suggests that Bmi-1 levels in endometrial carcinoma tissues may be useful as a reliable proliferation and prognostic biomarker. Recently, the promise of anti-Bmi-1 strategies for the treatment of endometrial carcinoma has been detected. Our results provide fundamental data regarding this anti-Bmi-1 strategy." @default.
• W3005642013 created "2020-02-24" @default.
• W3005642013 creator A5009365134 @default.
• W3005642013 creator A5010855291 @default.
• W3005642013 creator A5017371065 @default.
• W3005642013 creator A5027764683 @default.
• W3005642013 creator A5028322085 @default.
• W3005642013 creator A5058029843 @default.
• W3005642013 creator A5059355159 @default.
• W3005642013 date "2020-02-12" @default.
• W3005642013 modified "2023-09-25" @default.
• W3005642013 title "Bmi-1 Immunohistochemical Expression in Endometrial Carcinoma is Correlated with Prognostic Activity" @default.
• W3005642013 cites W1497210578 @default.
• W3005642013 cites W1880985771 @default.
• W3005642013 cites W1976641568 @default.
• W3005642013 cites W1984974202 @default.
• W3005642013 cites W2002265341 @default.
• W3005642013 cites W2031222466 @default.
• W3005642013 cites W2033618861 @default.
• W3005642013 cites W2034611105 @default.
• W3005642013 cites W2035269440 @default.
• W3005642013 cites W2057390343 @default.
• W3005642013 cites W2087172939 @default.
• W3005642013 cites W2087663062 @default.
• W3005642013 cites W2092015913 @default.
• W3005642013 cites W2096590516 @default.
• W3005642013 cites W2125713917 @default.
• W3005642013 cites W2126486896 @default.
• W3005642013 cites W2134596627 @default.
• W3005642013 cites W2139538823 @default.
• W3005642013 cites W2143645933 @default.
• W3005642013 cites W2145653081 @default.
• W3005642013 cites W2154128690 @default.
• W3005642013 cites W2221921894 @default.
• W3005642013 cites W2273058288 @default.
• W3005642013 cites W2345866782 @default.
• W3005642013 cites W2395612197 @default.
• W3005642013 cites W2397086611 @default.
• W3005642013 cites W2410066162 @default.
• W3005642013 cites W2434797444 @default.
• W3005642013 cites W2558156847 @default.
• W3005642013 cites W2581514666 @default.
• W3005642013 cites W2587709415 @default.
• W3005642013 cites W2588587312 @default.
• W3005642013 cites W2883065064 @default.
• W3005642013 cites W2892313110 @default.
• W3005642013 cites W2910165589 @default.
• W3005642013 cites W2922204959 @default.
• W3005642013 cites W2996895767 @default.
• W3005642013 cites W4211047904 @default.
• W3005642013 doi "https://doi.org/10.3390/medicina56020072" @default.
• W3005642013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7074093" @default.
• W3005642013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32059385" @default.
• W3005642013 hasPublicationYear "2020" @default.
• W3005642013 type Work @default.
• W3005642013 sameAs 3005642013 @default.
• W3005642013 citedByCount "4" @default.
• W3005642013 countsByYear W30056420132021 @default.
• W3005642013 countsByYear W30056420132022 @default.
• W3005642013 countsByYear W30056420132023 @default.
• W3005642013 crossrefType "journal-article" @default.
• W3005642013 hasAuthorship W3005642013A5009365134 @default.
• W3005642013 hasAuthorship W3005642013A5010855291 @default.
• W3005642013 hasAuthorship W3005642013A5017371065 @default.
• W3005642013 hasAuthorship W3005642013A5027764683 @default.
• W3005642013 hasAuthorship W3005642013A5028322085 @default.
• W3005642013 hasAuthorship W3005642013A5058029843 @default.
• W3005642013 hasAuthorship W3005642013A5059355159 @default.
• W3005642013 hasBestOaLocation W30056420131 @default.
• W3005642013 hasConcept C121608353 @default.
• W3005642013 hasConcept C126322002 @default.
• W3005642013 hasConcept C142724271 @default.
• W3005642013 hasConcept C143998085 @default.
• W3005642013 hasConcept C199835354 @default.
• W3005642013 hasConcept C204232928 @default.
• W3005642013 hasConcept C2777088508 @default.
• W3005642013 hasConcept C2777546739 @default.
• W3005642013 hasConcept C2910938049 @default.
• W3005642013 hasConcept C29537977 @default.
• W3005642013 hasConcept C502942594 @default.
• W3005642013 hasConcept C71924100 @default.
• W3005642013 hasConcept C86803240 @default.
• W3005642013 hasConceptScore W3005642013C121608353 @default.
• W3005642013 hasConceptScore W3005642013C126322002 @default.
• W3005642013 hasConceptScore W3005642013C142724271 @default.
• W3005642013 hasConceptScore W3005642013C143998085 @default.
• W3005642013 hasConceptScore W3005642013C199835354 @default.
• W3005642013 hasConceptScore W3005642013C204232928 @default.
• W3005642013 hasConceptScore W3005642013C2777088508 @default.
• W3005642013 hasConceptScore W3005642013C2777546739 @default.
• W3005642013 hasConceptScore W3005642013C2910938049 @default.
• W3005642013 hasConceptScore W3005642013C29537977 @default.
• W3005642013 hasConceptScore W3005642013C502942594 @default.
• W3005642013 hasConceptScore W3005642013C71924100 @default.
• W3005642013 hasConceptScore W3005642013C86803240 @default.
• W3005642013 hasIssue "2" @default.
• W3005642013 hasLocation W30056420131 @default.
• W3005642013 hasLocation W30056420132 @default.

• next